Envenoming by Viridovipera stejnegeri snake: a patient with liver cirrhosis presenting disruption of hemostatic balance

J Venom Anim Toxins Incl Trop Dis. 2017 Feb 14:23:10. doi: 10.1186/s40409-017-0096-9. eCollection 2017.

Abstract

Background: In most cases of envenoming by the green habu Viridovipera stejnegeri in Taiwan coagulopathy is not observed.

Case presentation: Herein, we describe the case of a patient with liver cirrhosis who developed venom-induced consumptive coagulopathy after V. stejnegeri bite. Laboratory investigation revealed the following: prothrombin time > 100 s (international normalized ratio > 10), activated partial thromboplastin time > 100 s, fibrinogen < 50 mg/dL, and fibrin degradation product > 80 μg/mL. The patient recovered after administration of bivalent hemorrhagic antivenom, vitamin K, fresh frozen plasma and cryoprecipitate.

Conclusion: The liver, directly involved in the acute phase reaction, is the main responsible for neutralization of animal toxins. Any patient with history of liver cirrhosis bitten by a venomous snake, even those whose venoms present low risk of coagulopathy, should be very carefully monitored for venom-induced consumptive coagulopathy (VICC), since the hemostatic balance may be disrupted.

Keywords: Coagulopathy; Liver cirrhosis; Snakebite.

Publication types

  • Case Reports